[1
]
Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus,
Denmark; European Society for Clinical Microbiology and Infectious Diseases Task Force
for Emerging Infections, Basel, Switzerland; International Society for Infectious
Diseases. Electronic address: eskild.petersen@gmail.com.
[2
]
Department of Medicine & Therapeutics and Stanley Ho Centre for Emerging Infectious
Diseases, The Chinese University of Hong Kong, Hong Kong Special Administrative Region,
Hong Kong, China. Electronic address: dschui@cuhk.edu.hk.
[3
]
Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh,
PA, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,
Baltimore, MD, USA; Division of Infectious Diseases, Department of Medicine, Stellenbosch
University, Faculty of Medicine and Health Sciences Cape Town, South Africa. Electronic
address: jbn16@pitt.edu.
[4
]
Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of Congo; Institute
of Tropical Medicine, University of Tübingen, Germany. Electronic address: fntoumi@fcrm-congo.com.
[5
]
International Society for Infectious Diseases; Translational Research Unit, National
Institute for Infectious Diseases Lazzaro Spallanzani- Istituto di Ricovero e Cura
a Carattere Scientifico (IRCCS), 00149 Rome, Italy. Electronic address: delia.goletti@inmi.it.
[6
]
Division of Clinical Pharmacology, Department of Global Public Health, Karolinska
Institutet, Karolinska University Hospital, Stockholm, Sweden. Electronic address:
Eleni.Aklillu@ki.se.
[7
]
Department of Biotechnology National Centre for Cell Science, Pune, India. Electronic
address: avinash.nccs@gmail.com.
[8
]
European Developing Countries Clinical rials partnership (EDCTP) Africa Office, Cape
Town, South Africa. Electronic address: nyirenda@edctp.org.
[9
]
Bacteriology Department, Noguchi Memorial Institute for Medical Research, University
of Ghana, Ghana. Electronic address: DYeboah-Manu@noguchi.ug.edu.gh.
[10
]
Department of Microbiology, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
Electronic address: giovanni.satta@nhs.net.
[11
]
Coalition for Epidemic Preparedness Innovations, Washington, DC, USA. Electronic address:
chrisdacosta26@gmail.com.
[12
]
Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, and Department
of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz
University, Jeddah, Saudi Arabia. Electronic address: eazhar@kau.edu.sa.
[13
]
International Society for Infectious Diseases; European Developing Countries Clinical
rials partnership (EDCTP) Africa Office, Cape Town, South Africa; School of Community
Health Sciences, Njala University, Bo, Sierra Leone. Electronic address: bockarie@edctp.org.
[14
]
Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat,
Oman. Electronic address: salabri@gmail.com.
[15
]
Centre for Clinical Microbiology, Division of Infection and Immunity, University College
London, London, UK. Electronic address: t.mchugh@ucl.ac.uk.
[16
]
Master's Program of Clinical Epidemiology and Biostatistics, Universidad Científica
del Sur, Lima, Peru; Gilbert and Rose- Marie Chagoury School of Medicine, Lebanese
American University, Beirut 1102, Lebanon. Electronic address: arodriguezmo@cientifica.edu.pe.
[17
]
Department of Medicine and Infectious Diseases, Christian Medical College, Vellore,
India. Electronic address: georgemvarghese@hotmail.com.
[18
]
Department of Infection, Division of Infection and Immunity, Centre for Clinical Microbiology,
University College London and NIHR Biomedical Research, Centre, University College
London Hospitals NHS Foundation Trust, London NW1 OPE, UK. Electronic address: a.zumla@ucl.ac.uk.
